UPDATE: Teva Pharmaceutical Posts Upbeat Q4 Earnings

Teva Pharmaceutical Industries TEVA reported better-than-expected fourth-quarter earnings. Teva's quarterly earnings, excluding one-time items, came in at $1.42 per share, versus $1.32 per share. Its revenue gained 3% to $5.43 billion. However, analysts were expecting earnings of $1.40 per on revenue of $5.19 billion. Teva shares gained 0.12% to $45.45 in pre-market trading.